Treosulfan Active Not Recruiting Phase 3 Trials for Leukemia Acute Myeloid Leukemia (AML) / Myelodysplastic Syndrome Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00822393Clinical Phase III Trial Treosulfan-based Conditioning Versus Reduced-intensity Conditioning (RIC)